2025 Marks Major Advancements in Incretin Therapies for Diabetes
Diabetes treatment is undergoing a significant transformation in 2025, primarily driven by advancements in incretin therapies. The rise of GLP-1 receptor agonists has captured attention across various medical specialties, with…